Indivior Pharmaceuticals Inc. Common Stock vs JPMorgan Ultra Short Income ETF — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while JPMorgan Ultra Short Income ETF trades at $50.28 (market cap $42.48B). The key difference: JPMorgan Ultra Short Income ETF is far larger — about 10.2× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and JPMorgan Ultra Short Income ETF for 47 Days on average.
| INDV | JPST | |
|---|---|---|
Market Cap | $4.18B | $42.48B |
Volume | 1,819,746 | 7,443,811 |
Sector | Health | Fixed Income |
52-Week High | $41.83 | $50.78 |
52-Week Low | $24.09 | $50.22 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $4.47B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPMorgan Ultra-Short Income ETF (JPST) trades at $50.31 with minimal daily movement, reflecting its ultra-short bond strategy focused on capital preservation. The technical picture shows bearish momentum with RSI indicators mixed, while fundamental data remains limited for this income-focused ETF. Recent news highlights institutional positioning changes and ongoing investor interest in ultrashort bond strategies amid rate uncertainty.
JPST offers investors exposure to high-quality, short-duration bonds with regular dividend distributions. The fund faces competition from similar ultrashort ETFs and sensitivity to Federal Reserve policy changes. Current market conditions favor cash-alternative strategies, though expense ratios and active management performance remain key considerations for investors seeking yield with minimal risk.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →